Investment Trusts

The Biotech Growth Trust PLC

BIOG:LSE

The Biotech Growth Trust PLC

Actions
  • Price (GBX)944.00
  • Today's Change19.00 / 2.05%
  • Shares traded99.89k
  • 1 Year change+14.29%
  • Beta0.6318
Data delayed at least 20 minutes, as of May 31 2024 17:08 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for investment trust price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Top holdings

43.85%Per cent of portfolio in top holdings
Holding% of portfolio
Amgen Inc7.45%
Biogen Inc6.35%
Janux Therapeutics Inc Ordinary Shares6.17%
Regeneron Pharmaceuticals Inc4.70%
Sarepta Therapeutics Inc4.43%
Neurocrine Biosciences Inc4.25%
Vaxcyte Inc Ordinary Shares3.61%
Apellis Pharmaceuticals Inc3.55%
Scholar Rock Holding Corp3.34%
As of Feb 29 2024. Top holdings excludes cash and cash equivalents.

Sector weighting

Sector% of portfolio
Healthcare103.21%
As of Apr 30 2024.

Regional holdings

Holding% of portfolio
USA96.29%
China3.76%
Canada1.77%
Germany1.50%
As of Apr 30 2024.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.